LumiThera Closes Series C Round of Financing

SEATTLE, July 8, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed its Series C financing. The company raised…

About the Author

has written 41555 stories on this site.

Copyright © 2010 Business and Corporate News.